Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2025)

Cresco Labs' Long-Term Deferred Tax history spans 7 years, with the latest figure at $13.5 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 2.85% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $13.5 million, up 2.85%, while the annual FY2025 figure was $13.5 million, 2.85% up from the prior year.
  • Long-Term Deferred Tax reached $13.5 million in Q4 2025 per CRLBF's latest filing, up from $13.1 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $13.5 million in Q4 2025 to a low of $26000.0 in Q4 2022.
  • Average Long-Term Deferred Tax over 5 years is $9.0 million, with a median of $11.5 million recorded in 2023.
  • Peak YoY movement for Long-Term Deferred Tax: tumbled 99.6% in 2022, then skyrocketed 44311.54% in 2023.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $6.6 million in 2021, then crashed by 99.6% to $26000.0 in 2022, then surged by 44311.54% to $11.5 million in 2023, then increased by 13.68% to $13.1 million in 2024, then increased by 2.85% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Long-Term Deferred Tax are $13.5 million (Q4 2025), $13.1 million (Q4 2024), and $11.5 million (Q4 2023).